Huntington National Bank’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4257 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4193 |
|
|
2025
Q3 | $0 | Sell |
1
-11
| -92% | -$86 | ﹤0.01% | 4177 |
|
|
2025
Q2 | $69 | Hold |
12
| – | – | ﹤0.01% | 2782 |
|
|
2025
Q1 | $95 | Buy |
12
+11
| +1,100% | +$91 | ﹤0.01% | 2708 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4212 |
|
|
2024
Q3 | $0 | Sell |
1
-60
| -98% | -$775 | ﹤0.01% | 4191 |
|
|
2024
Q2 | $760 | Hold |
61
| – | – | ﹤0.01% | 2356 |
|
|
2024
Q1 | $287 | Buy |
61
+60
| +6,000% | +$278 | ﹤0.01% | 2405 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3922 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3807 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3662 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3560 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2271 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2297 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2260 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2214 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1955 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1869 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1760 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1726 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1682 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1676 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1741 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1813 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1689 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$8 | ﹤0.01% | 1733 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1713 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1797 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1815 |
|
|
2014
Q1 | – | Sell |
-12
| Closed | -$1K | – | 1405 |
|
|
2013
Q4 | $1K | Sell |
12
-12
| -50% | -$848 | ﹤0.01% | 1686 |
|
|
2013
Q3 | $2K | Hold |
24
| – | – | ﹤0.01% | 1669 |
|
|
2013
Q2 | $0 | Buy |
+24
| New | +$1.04K | ﹤0.01% | 1733 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Huntington National Bank's NVAX Position: Q1 2026 in Review
Huntington National Bank held its Novavax (NVAX) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4257.
Huntington National Bank first reported a position in NVAX in Q2 2013 and has held it in 31 quarters since. The position peaked at $2K in Q3 2013. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Huntington National Bank held 1 share of Novavax worth $0 as of Q1 2026.
- Huntington National Bank left its Novavax share count unchanged in Q1 2026.
- Novavax made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4257 holding.
- Huntington National Bank first reported a position in Novavax in Q2 2013 and has held it in 31 quarters since.
- Huntington National Bank's Novavax position peaked at $2K in Q3 2013.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.